EUVIMEDEUVIMED entdecken
Crossref

Prognosis of Patients with Metastatic Soft Tissue Sarcoma: Advances in Recent Years

Jakob Lochner, Franka Menge, Nikolaos Vassos, Peter Hohenberger, Bernd Kasper

Oncology Research and Treatment · 2020 · 43 (11) · 613-619

DOI: 10.1159/000509519 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research and Treatment, online erschienen am 27.08.2020. Verfasst von Jakob Lochner und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sarcoma Unit, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The objective of this study was to investigate the prognosis of patients with metastatic soft tissue sarcomas (STS) and to define prognostic indicators for overall survival (OS).

Methods

All patients who were treated at the Sarcoma Unit at the Mannheim University Medical Center between 2010 and 2016 and who developed metastatic disease deriving from a STS were included in this retrospective analysis. OS was investigated using data from clinical records and German registry offices. Clinical and pathological characteristics were recorded and analyzed.

Results

A total number of 212 patients developed metastatic disease from STS during that period. Median OS after first documentation of metastatic disease was 24 months (95% CI 21–33). 1-, 2-, and 5-year OS rates were 70.0% (95% CI 64–77), 49.9% (95% CI 43–58), and 24.8% (95% CI 19–33), respectively. In multivariate analysis, significant predictors for mortality appeared to be gender, age, location and size of the primary tumor, histology, and disease-free interval.

Conclusion

Being treated in a high-volume STS reference center in Germany, patients with metastatic disease could demonstrate an increased OS compared to former analyses. These data can be used as a benchmark for upcoming studies and highlight that further research on treatment strategies in this rare disease is urgently needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease-Free SurvivalFemaleGermanyHumansKaplan-Meier EstimateMaleMiddle AgedMultivariate AnalysisNeoplasm GradingNeoplasm MetastasisPrognosisRetrospective StudiesSarcomaSoft Tissue NeoplasmsSurvival Rate

Stichwörter der Autor:innen

MetastasisOverall survivalPrognosisPrognostic factorsSoft tissue sarcoma

Autor:innen und Institutionen

  • Sarcoma Unit, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany.
  • Sarcoma Unit, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany, mail@berndkasper.de.

Zitieren

APA

Lochner, J., Menge, F., Vassos, N., Hohenberger, P., & Kasper, B. (2020). Prognosis of Patients with Metastatic Soft Tissue Sarcoma: Advances in Recent Years. Oncology Research and Treatment, 43(11), 613-619. https://doi.org/10.1159/000509519

Vancouver

Lochner J, Menge F, Vassos N, Hohenberger P, Kasper B. Prognosis of Patients with Metastatic Soft Tissue Sarcoma: Advances in Recent Years. Oncology Research and Treatment. 2020;43(11):613-619. doi:10.1159/000509519

BibTeX
@article{Lochner2020,
  author = {Lochner, Jakob and Menge, Franka and Vassos, Nikolaos and Hohenberger, Peter and Kasper, Bernd},
  title = {Prognosis of Patients with Metastatic Soft Tissue Sarcoma: Advances in Recent Years},
  journal = {Oncology Research and Treatment},
  year = {2020},
  volume = {43},
  number = {11},
  pages = {613--619},
  doi = {10.1159/000509519}
}
Kostenlos starten →